3 Dirt Cheap Stocks to Buy Right Now [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
By most metrics, the stock market is priced at a premium these days. But that doesn't mean bargains can't still be found. Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP) Gilead Sciences (NASDAQ: GILD) , and Pfizer (NYSE: PFE) You can still get in on the ground floor Valuing relatively small biotech companies that generate little-to-no revenue is not an exact science. Even so, CRISPR Therapeutics, a gene-editing specialist, looks cheap at its current levels. CRISPR Therapeutics' market cap is $4.2 billion despite the recent approval of Casgevy, a treatment for two blood-related diseases it developed in collaboration with Vertex Pharmaceuticals CRISPR Therapeutics and Vertex Pharmaceuticals are looking at a massive opportunity with Casgevy. The medicine costs $2.2 million in the U.S. They estimate a market of 35,000 patients in the U.S. and Europe, with an additional
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (NASDAQ:CRSP) shareholders have endured a 59% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Ark Next Generation Internet ETF vs. Ark Innovation ETF: Which Is Best for You? [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 8/5/24 - Miss
CRSP
Sec Filings
- 8/12/24 - Form 4
- 8/5/24 - Form S-3ASR
- 8/5/24 - Form S-8
- CRSP's page on the SEC website